Lisata Therapeutics Inc Sustainability Reports
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its lead product candidate is certepetide, which is designed to enable anti-cancer drugs to target and penetrate solid tumors more effectively.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493002287F62M3EGQ04
FIGI: BBG001SBTRW6
1 reports from 2022 to 2022
